ES2194841T3 - Procedimiento de produccion de vacunas bacterianas gram negativas. - Google Patents
Procedimiento de produccion de vacunas bacterianas gram negativas.Info
- Publication number
- ES2194841T3 ES2194841T3 ES92925307T ES92925307T ES2194841T3 ES 2194841 T3 ES2194841 T3 ES 2194841T3 ES 92925307 T ES92925307 T ES 92925307T ES 92925307 T ES92925307 T ES 92925307T ES 2194841 T3 ES2194841 T3 ES 2194841T3
- Authority
- ES
- Spain
- Prior art keywords
- vaccine
- gram
- negative bacterial
- pct
- mineral carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
SE PROPORCIONA EN ESTE INVENTO UN NUEVO METODO DE PREPARAR VACUNAS CONTRA BACTERIAS GRAM - NEGATIVAS. EL METODO COMPRENDE PROPORCIONAR UN CONCENTRADO DE PREPARACION ANTIGENICA BACTERIANA GRAM - NEGATIVA, ABSORBER LA PREPARACION CON UN PORTADOR MINERAL CAPAZ DE ENLAZAR LA ENDOTOXINA LIBRE EN LA PREPARACION ANTIGENICA EN UNA CANTIDAD EFECTIVA PARA PRODUCIR UN ENLACE OPTIMO DE ENDOTOXINA Y ANTIGENO Y DILUIR LA PREPARACION ABSORBENTE PARA EMPLEARLA EN UNA VACUNA. TAMBIEN SE PROPORCIONA EN ESTE INVENTO UNA VACUNA PRODUCIDA POR EL METODO DEL INVENTO. TAMBIEN SE PROPORCIONA POR ESTE INVENTO UNA VACUNA BACTERIANA GRAM - NEGATIVA EN DONDE LA MEJORA COMPRENDE UNA CONCENTRACION DE UN PORTADOR MINERAL EN LA VACUNA QUE ES MENOR QUE 5.0 % V/V. TAMBIEN SE PROPORCIONA EN ESTE INVENTO UNA VACUNA BACTERIANA GRAM - NEGATIVA QUE COMPRENDE UN PORTADOR MINERAL EN DONDE LA CANTIDAD DEL PORTADOR MINERAL EN LA VACUNA SE PREDETERMINA POR EL METODO DEL INVENTO. TAMBIEN SE PROPORCIONA EN ESTE INVENTO UN METODO DE VACUNAR UN ANIMAL CONTRA LAS INFECCIONES BACTERIANAS GRAM NEGATIVAS QUE COMPRENDE ADMINISTRAR AL ANIMAL UNA CANTIDAD EFECTIVA DE UNA VACUNA DE ESTE INVENTO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79248891A | 1991-11-15 | 1991-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2194841T3 true ES2194841T3 (es) | 2003-12-01 |
Family
ID=25157051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92925307T Expired - Lifetime ES2194841T3 (es) | 1991-11-15 | 1992-11-13 | Procedimiento de produccion de vacunas bacterianas gram negativas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5616328A (es) |
EP (1) | EP0669971B1 (es) |
JP (1) | JP3043809B2 (es) |
AT (1) | ATE234916T1 (es) |
AU (1) | AU667858B2 (es) |
CA (1) | CA2123222C (es) |
DE (1) | DE69232969T2 (es) |
DK (1) | DK0669971T3 (es) |
ES (1) | ES2194841T3 (es) |
WO (1) | WO1993010216A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE183194T1 (de) * | 1994-04-28 | 1999-08-15 | Takeda Chemical Industries Ltd | Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis |
US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
US6749831B1 (en) | 1997-05-16 | 2004-06-15 | Medical Defense Technology, Llc | Vaccine against lipopolysaccharide core |
US6713071B1 (en) * | 1998-10-22 | 2004-03-30 | Pfizer Inc. | Proteins from actinobacillus pleuropneumoniae |
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
AU776847B2 (en) * | 1999-01-29 | 2004-09-23 | Zoetis Services Llc | Erysipelothrix rhusiopathiae antigens and vaccine compositions |
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
US6765372B2 (en) | 2001-12-14 | 2004-07-20 | Intersil Americas Inc. | Programmable current-sensing circuit providing continuous temperature compensation for DC-DC Converter |
US20060073167A1 (en) * | 2002-12-18 | 2006-04-06 | Techno Network Shikoku Ltd. | Vaccine for fish cold-water disease |
US7521059B2 (en) * | 2004-06-14 | 2009-04-21 | Fenwick Bradley W | Kennel cough vaccine |
US20080193468A1 (en) * | 2004-09-08 | 2008-08-14 | Children's Medical Center Corporation | Method for Stimulating the Immune Response of Newborns |
EP2793918B1 (en) | 2011-12-19 | 2019-09-11 | The Rockefeller University | Hdc-sign binding peptides |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
WO2022114921A1 (ko) * | 2020-11-30 | 2022-06-02 | 주식회사 엘지화학 | 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법 |
CN113670914B (zh) * | 2021-08-19 | 2024-03-08 | 青岛易邦生物工程有限公司 | 一种油乳剂灭活疫苗的细菌内毒素检测方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
US4465665A (en) * | 1982-03-04 | 1984-08-14 | Smithkline-Rit | Detoxified E. coli neurotoxin, preparation thereof and immunological preparations containing it |
US4705686A (en) * | 1986-05-09 | 1987-11-10 | American Cyanamid | Process for the preparation of acellular Bordetalla pertussis vaccine |
US4789544A (en) * | 1986-05-23 | 1988-12-06 | Midcon Labs. Inc. | Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation |
US5019388A (en) * | 1986-10-14 | 1991-05-28 | Norden Laboratories Inc. | Bordetella bronchiseptica vaccine |
US5101019A (en) * | 1987-05-22 | 1992-03-31 | Takeda Chemical Industries, Ltd. | Method for removing pertussis endotoxin, a pertussis toxoid and its production |
AU8195391A (en) * | 1990-06-13 | 1992-01-07 | Smithkline Beecham Corporation | Pasteurella multocida toxoid vaccines |
-
1992
- 1992-11-13 AT AT92925307T patent/ATE234916T1/de active
- 1992-11-13 ES ES92925307T patent/ES2194841T3/es not_active Expired - Lifetime
- 1992-11-13 EP EP92925307A patent/EP0669971B1/en not_active Expired - Lifetime
- 1992-11-13 AU AU31413/93A patent/AU667858B2/en not_active Expired
- 1992-11-13 DK DK92925307T patent/DK0669971T3/da active
- 1992-11-13 DE DE69232969T patent/DE69232969T2/de not_active Expired - Lifetime
- 1992-11-13 JP JP5509495A patent/JP3043809B2/ja not_active Expired - Lifetime
- 1992-11-13 CA CA002123222A patent/CA2123222C/en not_active Expired - Lifetime
- 1992-11-13 WO PCT/US1992/009944 patent/WO1993010216A1/en active IP Right Grant
- 1992-11-13 US US08/240,649 patent/US5616328A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0669971B1 (en) | 2003-03-19 |
DK0669971T3 (da) | 2003-04-22 |
AU3141393A (en) | 1993-06-15 |
DE69232969T2 (de) | 2004-08-05 |
ATE234916T1 (de) | 2003-04-15 |
CA2123222C (en) | 2001-02-27 |
WO1993010216A1 (en) | 1993-05-27 |
JP3043809B2 (ja) | 2000-05-22 |
EP0669971A4 (en) | 1995-04-19 |
AU667858B2 (en) | 1996-04-18 |
US5616328A (en) | 1997-04-01 |
JPH07501333A (ja) | 1995-02-09 |
DE69232969D1 (de) | 2003-04-24 |
CA2123222A1 (en) | 1993-05-27 |
EP0669971A1 (en) | 1995-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2194841T3 (es) | Procedimiento de produccion de vacunas bacterianas gram negativas. | |
IL138798A0 (en) | Vaccines and antibodies against bacterial pneumococcal infection | |
HUP0002475A2 (hu) | Módosított immunogén pneumolizinkészítmények mint vakcinák | |
AU1915995A (en) | Active immunization using a siderophore receptor protein | |
CY1107571T1 (el) | Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου | |
CA2022420A1 (en) | Escherichia coli vaccine | |
BR9713312B1 (pt) | preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária. | |
HUP9801223A2 (hu) | Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel | |
Yang et al. | Specific humoral immune response induced by propionibacterium acnes can prevent Actinobacillus pleuropneumoniae infection in mice | |
DE69527986D1 (de) | Antigene arznei zur behandlung oder vorbeugung | |
ES8802117A1 (es) | Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas | |
ATE356633T1 (de) | Vakzin für einen nicht typisierbaren haemophilus influenzae stamm | |
AU673344B2 (en) | Vaccines based on streptokinase | |
DE69333402D1 (en) | Impfstoff beinhaltend bacterin und toxoid aus pasteurella haemolytica typ a-1 | |
PL341541A1 (en) | Isolated strains of staphyloccoccus aureus and vaccines prepared of them | |
AU4778297A (en) | Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same | |
NO931655L (no) | Syntetiske lipid a glykokonjugatantigener for anvendelse i vaksiner | |
WO2023172741A3 (en) | A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine comprising b- and t-cell antigens, immunogenic composition, and uses thereof | |
JP3270473B2 (ja) | パスツレラ・マルトサイダ・トキソイドワクチン | |
SU1405300A1 (ru) | Штамм бактерий chlamydia psittaci, используемый для изготовления инактивированной вакцины против хламидиоза свиней |